Clinical Trial Update: Rituximab, Vaccine Therapy, and GM-CSF in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

This document summarizes a Phase 2 clinical trial of rituximab with a vaccine therapy and GM-CSF in patients with Non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Rituximab (rituximab)
• Vaccine therapy
• sargramostim (sargramostim)

Snippet

Sponsor: Favrille | Conditions: Lymphoma | Phase 2 | Status: UNKNOWN